Page last updated: 2024-08-24

irinotecan and Cancer of Nasopharynx

irinotecan has been researched along with Cancer of Nasopharynx in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Garcia-Bournissen, F; Ito, S; Kim, R; Nathan, PC; Sakaguchi, S; Schwarz, UI	1
Cheung, YB; Chowbay, B; Leong, SS; Poon, D; Tan, EH	1
Cheung, YB; Chowbay, B; Lee, A; Lee, EJ; Poon, D; Sparreboom, A; Tan, EH; Zhou, Q	1

Trials

1 trial(s) available for irinotecan and Cancer of Nasopharynx

Article	Year
Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma. Cancer, 2005, Feb-01, Volume: 103, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma; Diarrhea; Disease Progression; Drug Administration Schedule; Female; Humans; Irinotecan; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Quality of Life; Salvage Therapy; Survival Analysis; Treatment Outcome	2005

Article

Year

Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma.

Cancer, 2005, Feb-01, Volume: 103, Issue:3

Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma; Diarrhea; Disease Progression; Drug Administration Schedule; Female; Humans; Irinotecan; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Quality of Life; Salvage Therapy; Survival Analysis; Treatment Outcome

2005

Other Studies

2 other study(ies) available for irinotecan and Cancer of Nasopharynx

Article	Year
Prolonged neutropenia after irinotecan-based chemotherapy in a child with polymorphisms of UGT1A1 and SLCO1B1. Archives of disease in childhood, 2009, Volume: 94, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Child; Female; Genetic Predisposition to Disease; Glucuronosyltransferase; Humans; Irinotecan; Liver-Specific Organic Anion Transporter 1; Nasopharyngeal Neoplasms; Neutropenia; Organic Anion Transporters; Polymorphism, Single Nucleotide; Rhabdomyosarcoma, Alveolar	2009
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer. British journal of clinical pharmacology, 2005, Volume: 59, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Asian People; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Camptothecin; Female; Genes, MDR; Genotype; Heterozygote; Homozygote; Humans; Irinotecan; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Nasopharyngeal Neoplasms; Neoplasm Proteins; Phenotype; Polymorphism, Single Nucleotide	2005

Article

Year

Prolonged neutropenia after irinotecan-based chemotherapy in a child with polymorphisms of UGT1A1 and SLCO1B1.

Archives of disease in childhood, 2009, Volume: 94, Issue:12

Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Child; Female; Genetic Predisposition to Disease; Glucuronosyltransferase; Humans; Irinotecan; Liver-Specific Organic Anion Transporter 1; Nasopharyngeal Neoplasms; Neutropenia; Organic Anion Transporters; Polymorphism, Single Nucleotide; Rhabdomyosarcoma, Alveolar

2009

Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer.

British journal of clinical pharmacology, 2005, Volume: 59, Issue:4

Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Asian People; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Camptothecin; Female; Genes, MDR; Genotype; Heterozygote; Homozygote; Humans; Irinotecan; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Nasopharyngeal Neoplasms; Neoplasm Proteins; Phenotype; Polymorphism, Single Nucleotide

2005